Jan S, Phadke K, Lam V, Branda S, Johnson D
Virol J. 2025; 22(1):52.
PMID: 40022100
PMC: 11869472.
DOI: 10.1186/s12985-025-02669-y.
Witwit H, Betancourt C, Cubitt B, Khafaji R, Kowalski H, Jackson N
Viruses. 2024; 16(9).
PMID: 39339839
PMC: 11436053.
DOI: 10.3390/v16091362.
Brouwer P, Perrett H, Beaumont T, Nijhuis H, Kruijer S, Burger J
Cell Rep. 2024; 43(9):114708.
PMID: 39243373
PMC: 11422484.
DOI: 10.1016/j.celrep.2024.114708.
Carr C, Crawford K, Murphy M, Galloway J, Haddox H, Matsen 4th F
Immunity. 2024; 57(9):2061-2076.e11.
PMID: 39013466
PMC: 11390330.
DOI: 10.1016/j.immuni.2024.06.013.
Hendrix S, Dartigue V, Hall H, Bawaria S, Kingma J, Bajaj B
Nat Commun. 2024; 15(1):5732.
PMID: 38977690
PMC: 11231238.
DOI: 10.1038/s41467-024-50068-8.
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection.
Golden J, Kwilas S, Hooper J
Vaccines (Basel). 2024; 12(6).
PMID: 38932403
PMC: 11209097.
DOI: 10.3390/vaccines12060674.
Cellular endosomal potassium ion flux regulates arenavirus uncoating during virus entry.
Shaw A, Tse H, Byford O, Plahe G, Moon-Walker A, Hover S
mBio. 2024; 15(7):e0168423.
PMID: 38874413
PMC: 11253613.
DOI: 10.1128/mbio.01684-23.
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
Zhang Z, Takenaga T, Fehling S, Igarashi M, Hirokawa T, Muramoto Y
J Virol. 2024; 98(7):e0071424.
PMID: 38809021
PMC: 11265444.
DOI: 10.1128/jvi.00714-24.
SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1P.
Hendrix S, Tan J, Ndoj K, Kingma J, Valiloo M, Zijlstra L
Mol Cell Biol. 2024; 44(4):123-137.
PMID: 38747374
PMC: 11110692.
DOI: 10.1080/10985549.2024.2348711.
Entry inhibitors as arenavirus antivirals.
Iyer K, Yan Z, Ross S
Front Microbiol. 2024; 15:1382953.
PMID: 38650890
PMC: 11033450.
DOI: 10.3389/fmicb.2024.1382953.
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors.
Lotke R, Petersen M, Sauter D
Viruses. 2024; 16(3).
PMID: 38543698
PMC: 10975521.
DOI: 10.3390/v16030332.
The underlying mechanisms of arenaviral entry through matriglycan.
Katz M, Diskin R
Front Mol Biosci. 2024; 11:1371551.
PMID: 38516183
PMC: 10955480.
DOI: 10.3389/fmolb.2024.1371551.
Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery.
Madigan V, Zhang Y, Raghavan R, Wilkinson M, Faure G, Puccio E
Proc Natl Acad Sci U S A. 2024; 121(11):e2307812120.
PMID: 38437549
PMC: 10945824.
DOI: 10.1073/pnas.2307812120.
Deep mutational scanning reveals functional constraints and antigenic variability of Lassa virus glycoprotein complex.
Carr C, Crawford K, Murphy M, Galloway J, Haddox H, Matsen 4th F
bioRxiv. 2024; .
PMID: 38370709
PMC: 10871245.
DOI: 10.1101/2024.02.05.579020.
Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.
Byford O, Shaw A, Tse H, Todd E, Alvarez-Rodriguez B, Hewson R
J Virol. 2024; 98(3):e0200623.
PMID: 38334330
PMC: 10949467.
DOI: 10.1128/jvi.02006-23.
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses.
Brouwer P, Perrett H, Beaumont T, Nijhuis H, Kruijer S, Burger J
bioRxiv. 2024; .
PMID: 38187682
PMC: 10769344.
DOI: 10.1101/2023.12.21.572918.
The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens.
Hastie K, Melnik L, Cross R, Klitting R, Andersen K, Saphire E
J Infect Dis. 2023; 228(Suppl 6):S359-S375.
PMID: 37849403
PMC: 10582522.
DOI: 10.1093/infdis/jiac266.
Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents.
Akash S, Baeza J, Mahmood S, Mukerjee N, Subramaniyan V, Islam M
Front Microbiol. 2023; 14:1206872.
PMID: 37497547
PMC: 10366616.
DOI: 10.3389/fmicb.2023.1206872.
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.
Perrett H, Brouwer P, Hurtado J, Newby M, Liu L, Muller-Krauter H
Cell Rep. 2023; 42(5):112524.
PMID: 37209096
PMC: 10242449.
DOI: 10.1016/j.celrep.2023.112524.
Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion.
Dong S, Mao W, Liu Y, Jia X, Zhang Y, Zhou M
Virol Sin. 2023; 38(3):380-386.
PMID: 37059226
PMC: 10311258.
DOI: 10.1016/j.virs.2023.04.003.